THANK YOU FOR SUBSCRIBING
Thoma Bravo's investment can provide significant operational and economic resources to the firm, allowing it to strengthen its position as a leader in the worldwide cardiac imaging sector.
Fremont, CA: Cardiovascular imaging has advanced tremendously in the twenty-first century. Every technology used to scan the heart has advanced over the previous two decades, such as echocardiography, cardiac magnetic resonance, cardiac CT, and nuclear cardiology. There's also been a significant development in hybrid and fusion modalities, which combine the unique characteristics of two imaging methods simultaneously, as well as the introduction of artificial intelligence (AI) and machine learning (ML) into clinical workflow.
Thoma Bravo, a renowned software investment firm, announced today that its strategic growth venture in Circle Cardiovascular Imaging Inc. ("Circle CVI"), the leading provider of cardiovascular imaging solutions, has been completed.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
"With the close of this transaction, we're excited to work with the Thoma Bravo team to accelerate our growth, drive continued product innovation and further solidify Circle CVI as the market leader," said Greg Ogrodnick, CEO and Co-Founder of Circle CVI. "Together, we can continue building even better solutions and products to serve cardiovascular professionals and their patients across the world."
Circle CVI is the major provider of AI-based cardiac imaging & reporting solutions, comprising cardiac MRI ("CMR") and CT imaging post-processing software. The firm has built a broad array of specialized, precise, and user-friendly solutions essential to precision medicine and empowers physicians to provide the greatest quality treatment to their patients. Thousands of clinical users utilize circle CVI's products in over 50 countries, including hospitals and academic organizations. Thoma Bravo's investment can provide significant operational and economic resources to the firm, allowing it to strengthen its position as a leader in the worldwide cardiac imaging sector.
"Circle CVI is the category leader in cardiac image post-processing solutions, and through our partnership we can help continue the company's momentum and advance its product offerings while unlocking new global growth opportunities," said Carl Press, a Partner at Thoma Bravo. "We are thrilled to work with Greg and the entire Circle CVI team and look forward to helping the company reach even greater heights."
Circle CVI's financial advisor was AGC Partners, while its legal counsel was Osler, Hoskin & Harcourt LLP. Thoma Bravo was represented by Kirkland & Ellis, LLP and McMillan LLP. The deal got funded by Deutsche Bank Credit Solutions and Direct Lending.
More in News